Genetic instability and atherosclerosis: Can somatic mutations account for the development of cardiovascular diseases?

Environmental and Molecular Mutagenesis

Volumn 35, Issue 4, 2000, Pages 265-269

  Andreassi, M G ^a   Botto, N ^a   Colombo, M G ^a   Biagini, A ^a   Clerico, A ^a  

^a G PASQUINUCCI HOSPITAL   (Italy)

Author keywords

Atherosclerosis; Cancer; DNA damage; Monoclonal hypothesis; Mutation

Indexed keywords

ARSENIC; CARCINOGEN; DIOXIN; ENVIRONMENTAL MUTAGEN; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; POLYCYCLIC AROMATIC HYDROCARBON; VINYL CHLORIDE;

ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CANCER; CARCINOGENESIS; CYTOGENETICS; DNA DAMAGE; IONIZING RADIATION; MICROSATELLITE INSTABILITY; REVIEW; RISK FACTOR; SOMATIC MUTATION;

ANIMALS; ARTERIOSCLEROSIS; HUMANS; MUTATION; NEOPLASMS; RISK FACTORS;

EID: 0033918175     PISSN: 08936692     EISSN: None     Source Type: Journal    
DOI: 10.1002/1098-2280(2000)35:4<265::AID-EM1>3.0.CO;2-M     Document Type: Review

References (57)

1. Andreassi MG, Picano E, Del Ry S, Petrozzi L, Giannessi D, Varga A. 1999. Effects of chronic long-term therapy with calcium-antagonist on cytogenetic damage in humans. J Hypertens 17:843-846.
2. Aviv A, Aviv H. 1997. Reflections on telomeres, growth, aging, and essential hypertension. Hypertension 29:1067-1072.
3. Benditt EP, Benditt JM. 1973. Evidence for a monoclonal origin of human atherosclerotic plaques. Proc Natl Acad Sci USA 70:1753-1756.
4. Bennet MR, Evan GI, Schwartz SM. 1995. Apoptosis of human vascular smooth muscle cells derived from normal vessel and coronary atherosclerotic plaques. J Clin Invest 95:2266-2274.
5. Bertazzi PA. 1989. Industrial disasters and epidemiology: a review of recent experiences. Scand J Work Environ Health 15:85-100.
6. Bridges BA., Bowyer DE, Hansen ES, Penn A, Wakabayashi K. 1990. The possible involvement of somatic mutations in the development of atherosclerotic plaque. Mutat Res 239:163-168.
7. Carstensen JM, Pershagen G, Eklund G. 1987. Mortality in relation to cigarette and pipe smoking: 16 years'observation of 25,000 Swedish men. J Epidemiol Community Health 41:166-172.
8. Casalone R, Granata P, Minelli E, Portentoso P, Giudici A, Righi R, Castelli P, Socrate A, Frigerio B. 1991. Cytogenetic analysis reveals clonal proliferation of smooth muscle cells in atherosclerotic plaques. Hum Genet 87:139-143.
9. Chen C, Wu M, Lee S. Wang J, Cheng S, Wu H. 1988. Atherogenicity and carcinogenicity of high-arsenic artesian well water: multiple risk factors related to malignant neoplasms of blackfoot disease. Arteriosclerosis 8:452-460.
10. Chung LM, Schwartz SM, Murry CE. 1998. Clonal architecture of normal and atherosclerotic aorta. Am J Pathol 152:913-923.
11. Conroy SC, Hart CE, Perez-Reyes N, Giachelli CM, Schwartz SM, McDougall JK. 1995. Characterization of human aortic smooth muscle cells expressing HPV 16 and E7 open reading frames. Am J Pathol 147:753-762.
12. Dartsh PC, Weiss HD, Betz E. 1990. Human vascular smooth muscle cells in culture: growth characteristics and protein pattern by use of serum-free media supplements. Eur J Cell Biol 51:285-294.
13. De Bono DP. 1998. Olovnikov's clock: telomeres, growth, aging, and essential hypertension. Heart 80:110-111.
14. De Flora S, Izzotti A, Walsh A, Degan P, Petrilli GL, Lewtas J. 1997. Molecular epidemiology of atherosclerosis. FASEB J 11:1021-1031.
15. Fossel M. 1998. Telomerase and the aging cell: implications for human health. JAMA 279:1732-1735.
16. Gordon D, Reidy MA, Benditt EP, Schwartz SM. 1990. Cell proliferation in human coronary arteries. Proc Natl Acad Sci USA 87:4600-4604.
17. Gown AM, Tsukada T, Ross R. 1986. Human atherosclerosis. II. Immunocytochemical analysis of the cellular composition of human atherosclerotic lesions. Am J Pathol 125:191-207.
18. Grossman E, Messerli FH, Goldbourt U. 1999. Does diuretic therapy increase the risk of renal cell carcinoma? Am J Cardiol 83:1090-1093.
19. Hagmar L, Bonassi S, Stromberg U, Brogger A, Knudsen LE, Norppa H. Reuterwall C. 1998. Chromosomal aberrations in lymphocytes predict human cancer: a report from the European Study Group on Cytogenetic Biomarkers and Health (ESCH). Cancer Res 58:4117-4121.
20. Hamet P. 1997. Cancer and hypertension: a potential for crosstalk? J Hypertens 15:1573-1577.
21. Hansen ES. 1990. Shared risk factors for cancer and atherosclerosis - a review of the epidemiological evidence. Mutat Res 239:163-179.
22. Harris CC. 1993. p53 - At the crossroads of molecular carcinogenesis and risk assessment. Science 262:1980-1981.
23. Hatzistamou J, Kiaris H, Ergazaki M, Spandidos DA. 1996. Loss of heterozygosity and microsatellite instability in human atherosclerotic plaques. Biochem Biophys Res Commun 225:186-190.
24. Hogstedt C. 1980. Dynamite - occupational exposure and health effects. Ph.D. Dissertation, Linköping, Sweden, p 1-34.
25. Jonasson L, Holm J, Skalli O, Bondjers G, Hansson GK. 1986. Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis 6:131-138.
26. Katsuda S, Coltrera MD, Ross R, Gown AM. 1993. Human atherosclerosis. IV. Immunocytochemical analysis of cell activation and proliferation in lesions of young adults. Am J Pathol 142:1787-1793.
27. Levine AJ. 1995. The genetic origins of neoplasia. JAMA 273:592.
28. Libby P, Hansson GK. 1991. Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions. Lab Invest 64:5-15.
29. Loeb LA. 1994. Microsatellite instability: marker of a mutator phenotype in cancer. Cancer Res 54:5059-5063.
30. Loftus CM, Biller J, Hart MN, Cornell SH, Hiratzka LF. 1987. Management of radiation induced accelerated carotid atherosclerosis. Arch Neurol 44:711-714.
31. Matturri L, Cazzullo A, Turconi P, Lavezzi AM. 1997. Cytogenetic aspects of cell proliferation in atherosclerotic plaques. Cardiologia 42:833-836.
32. McCaffrey TA, Du B, Consigli S, Szabo P, Bray PJ, Hartner L. Weksler BB, Sanborn TA, Bergman G, Bush HL Jr. 1997. Genomic instability in the type II TGF-beta I receptor gene in atherosclerotic and restenotic vascular cells. J Clin Invest 100:2182-2188.
33. Murry CE, Gipaya CT, Bartosek T, Benditt EP, Schwartz SM. 1997. Monoclonality of smooth muscle cells in human atherosclerosis. Am J Pathol 151:697-706.
34. Naber SP. 1994. Molecular pathology-detection of neoplasia. N Engl J Med 331:1508-1510.
35. Nurminen M, Hernherg S. 1985. Effects of intervention on the cardiovascular mortality of workers exposed to carbon disulfide: a 15 years follow up. Br J Ind Med 42:32-35.
36. O'Brien ER, Alpers CE, Stewart DK, Ferguson M, Tran N, Gordon D, Benditt EP, Hinohara T, Simpson JB, Schwartz SM. 1993. Proliferation in primary and restenotic coronary atherectomy tissue: implications for antiproliferative therapy. Circ Res 73:223-231.
37. Pahor M, Guralnik JM, Ferrucci L, Corti MC, Salive ME, Cerhan JR, Wallace RB, Havlik RJ. 1996. Calcium-channel blockade and incidence of cancer in aged populations. Lancet 348:493-197.
38. Parkes JL, Cardell RR, Hubbard FC Jr, Hubbard D, Meltzer A, Penn A. 1991. Cultured human atherosclerotic plaque smooth muscle cells retain transforming potential and display enhanced expression of the myc protooncogen. Am J Pathol 138:765-775.
39. Penn A. 1990. Mutational events in the etiology of arteriosclerotic plaques. Mutat Res 239:149-162.
40. Penn A, Garte SJ, Warren L, Nesta D, Mindich B. 1986. Transforming gene in human atherosclerotic plaque DNA. Proc Natl Acad Sci USA 83:7951-7955.
41. Renner SM, Massel D, Moon BC. 1999. Mediastinal irradiation: a risk factor for atherosclerosis of the internal thoracic arteries. Can J Cardiol 15:597-600.
42. Ross R, 1993. The pathogenesis of atherosclerosis: a perspective for the 1990's. Nature 362:801-809.
43. Ross R. 1999. Atherosclerosis - an inflammatory disease. N Engl J Med 340:115-126.
44. Ross R, Glomset J, Kariya B, Harker L. 1974. A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. Proc Natl Acad Sci USA 71:1207-1210.
45. Sadhu D, Ramos K. 1993. Modulation by retinoic acid of spontaneous and benzo(a)pyrene-induced C-HA-RAS expression. In: Bronzetti G, Hayatsu H, De Flora S, Waters MD, Shankel D, editors. Anti-mutagenesis and anticarcinogenesis mechanism. Portland, OR: Book News, Inc. Vol. III. p 263-268.
46. Schwartz SM, Murry CE. 1998. Proliferation and the monoclonal origins of atherosclerotic lesions. Annu Rev Med 49:437-160.
47. Spandidos DA, Ergazaki M, Arvanitis D, Kiaris H. 1996. Microsatellite instability in human atherosclerotic plaques. Biochem Biophys Res Commun 220:137-140.
48. Speir E, Modali R, Huang ES, Leon MB, Shawl F, Finkel T, Epstein SE. 1994. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science 265:391-394.
49. Tokunaga O, Satoh T, Yamasaki F, Wu L. 1998. Multinucleated variant endothelial cells (MVECs) in human aorta: chromosomal aneuploidy and elevated uptake of LDL. Semin Thromb Hemost 24: 279-84.
50. Trosko J, Chang C. 1980. An integrative hypothesis linking cancer, diabetes, and atherosclerosis: the role of mutations and epigenetic changes. Med Hypotheses 6: 455-468.
51. Tucker JD, Preston RJ. 1996. Chromosome aberrations, micronuclei, aneuploidy, sister chromatid exchanges, and cancer risk assessment. Mutat Res 365:147-159.
52. Urquidi V, Tarin D, Goodison S. 1998. Telomerase in cancer: clinical applications. Ann Med 30:419-430.
53. Van Schooten FJ, Hirvonen A, Maas LM, De Mol BA, Kleinjans JCS, Bell DA, Durrer JD. 1998. Putative susceptibility markers of coronary artery disease: association between VDR genotype, smoking, and aromatic DNA adduct levels in human right atrial tissue. FASEB J 12:1409-1417.
54. Vanni R, Licheri S. 1991. Clonal cytogenetic changes in atherosclerotic plaques including trisomy 20. Dis Markers 9:81-85.
55. Wakabayashi K. 1990. Animal studies suggesting involvement ot mutagen/ carcinogen exposure in atherosclerosis. Mutat Res 239:181-187.
56. Weinberg RA, Hanahan D. 1996. The molecular pathogenesis of cancer. In. Bishop JM, Weinberg RA, editors. Molecular oncology. New York: Scientific American, Inc. p 179-204.
57. Werner MH, Burger PC, Heinz ER, Friedman AH, Halperin EC, Schold SC. 1988. Intracranial atherosclerosis following radiotherapy. Neurology 38:1158-1160.